AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 39 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $225,000 | -10.0% | 17,057 | -15.3% | 0.00% | – |
| Q3 2019 | $250,000 | -26.9% | 20,129 | -5.2% | 0.00% | -100.0% |
| Q2 2019 | $342,000 | +3.0% | 21,229 | +101.2% | 0.00% | 0.0% |
| Q1 2019 | $332,000 | -0.3% | 10,549 | +3.9% | 0.00% | 0.0% |
| Q4 2018 | $333,000 | +11.0% | 10,149 | +2.0% | 0.00% | – |
| Q3 2018 | $300,000 | +16.3% | 9,949 | +3.1% | 0.00% | – |
| Q2 2018 | $258,000 | – | 9,649 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $40,558,975 | 64.38% |
| TFG Asset Management GP Ltd | 8,300,000 | $15,770,000 | 2.26% |
| Odey Asset Management Group Ltd | 2,499,400 | $4,748,860 | 1.43% |
| Deep Track Capital, LP | 15,000,000 | $28,500,000 | 1.20% |
| Nantahala Capital Management | 7,782,018 | $14,785,834 | 0.96% |
| DAFNA Capital Management LLC | 1,176,150 | $2,234,685 | 0.63% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $7,119,028 | 0.44% |
| ARMISTICE CAPITAL, LLC | 10,224,000 | $19,425,600 | 0.34% |
| CVI Holdings, LLC | 1,237,511 | $2,351,271 | 0.30% |
| HARBOR CAPITAL ADVISORS, INC. | 145,315 | $276,099 | 0.27% |